Suppr超能文献

白细胞介素-7激活肠道淋巴细胞。

Interleukin-7 activates intestinal lymphocytes.

作者信息

Bilenker M, Roberts A I, Brolin R E, Ebert E C

机构信息

Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019, USA.

出版信息

Dig Dis Sci. 1995 Aug;40(8):1744-9. doi: 10.1007/BF02212696.

Abstract

Human intestinal lymphocytes, particularly intraepithelial lymphocytes, proliferate minimally to some agents, like mitogens and stimuli of the CD3 pathway. This in vitro finding may be due, in part, to a loss of factors found in vivo. Three T-cell growth factors, IL-7, IL-9, and IL-12, were tested for their ability to stimulate the proliferation of intestinal lymphocytes. Both intraepithelial lymphocytes and lamina propria lymphocytes proliferated more vigorously to IL-7 than to IL-9 or IL-12, and only IL-7 increased stimulation through the CD3 pathway. The IL-7-induced response was IL-2-dependent: IL-2 receptors appeared on both intestinal lymphocyte types, and antibody to the IL-2 receptor blocked IL-7-induced proliferation. Both CD4+ and CD8+ T-cell subsets responded to this cytokine as shown by phenotype-depletion experiments and constancy in the CD4/CD8 ratios after culture with IL-7. In addition, the T-cell receptor alpha beta and gamma delta subsets responded equally well to IL-7. This newly described selective proliferative response of intestinal lymphocytes to IL-7, but not to IL-9 or IL-12, requires no preactivation and may enhance growth in vivo.

摘要

人类肠道淋巴细胞,尤其是上皮内淋巴细胞,对某些物质(如丝裂原和CD3途径的刺激物)的增殖反应极小。这种体外研究结果可能部分归因于体内某些因子的缺失。研究了三种T细胞生长因子,即白细胞介素-7(IL-7)、白细胞介素-9(IL-9)和白细胞介素-12(IL-12)刺激肠道淋巴细胞增殖的能力。与IL-9或IL-12相比,上皮内淋巴细胞和固有层淋巴细胞对IL-7的增殖反应更为强烈,并且只有IL-7能增强通过CD3途径的刺激。IL-7诱导的反应依赖于IL-2:两种肠道淋巴细胞类型上均出现IL-2受体,并且抗IL-2受体抗体可阻断IL-7诱导的增殖。表型去除实验表明,CD4⁺和CD8⁺T细胞亚群均对这种细胞因子有反应,并且在用IL-7培养后CD4/CD8比值保持恒定。此外,T细胞受体αβ和γδ亚群对IL-7的反应同样良好。肠道淋巴细胞对IL-7而非IL-9或IL-12的这种新描述的选择性增殖反应无需预先激活,并且可能会增强体内生长。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验